Skip to content

Clinical Study on SHARAPUNKHA In the Management of Nonalcoholic fatty Liver disease

A Pharmaco clinical and Phytochemical study on SHARAPUNKHA(Tephrosia purpurea)in the management of early stage of Yakrutodara w.s.r to Nonalcoholic fatty liver disease - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078212
Enrollment
30
Registered
2024-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Ayurevda and Unani Tibbia college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either sex between the age of 20 - 70 years suffering from Non alcoholic fatty liver disease grade 1 and 2 0r Diagnosed case of NAFLD Grade 1 and 2 reporting to General OPD of Tibbia college hospital

Exclusion criteria

Exclusion criteria: 1 Patient having H/O cardiovascular diseases and patient with uncontrolled HTN(BP being persistently above 140/90 mm Hg despite medication 2 Patient with uncontrolled diabetes and those who are on insulin therapy 3 pregnant and lactating patients 4 patients with communicable diseases like TB, varicella zoster etc 5 other hepatic pathologies (Eg-jaundice)or patient with elevated level of bilirubin etc.

Design outcomes

Primary

MeasureTime frame
parameter for assessment of study outcome objective criteria includes LFT,USG,Fibroscan Improvement in subjective criteria likes Fatigue,Pain in epigastrium,Anorexia,NauseaTimepoint: 3 month

Secondary

MeasureTime frame
Evaluating the safety of drug Sharapunkha(Tephrosia purpurea) which will be assessed with KFTTimepoint: After 15 the day of trail and completion of trail ie 3 month

Countries

India

Contacts

Public ContactDr Banshidhar Behera

Ayurveda and Unani Tibbia college New delhi

drbanshi@rediffmail.com9414458895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026